Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

CULLINAN ONCOLOGY, INC.

(CGEM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CULLINAN ONCOLOGY, INC.
01/24Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application ..
GL
01/24Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application ..
AQ
01/24Cullinan Oncology, Inc. Announces U.S. FDA Clearance of Investigational New Drug Applic..
CI
01/06Cullinan Oncology : Corporate Presentation January 2023
PU
01/03Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2022Cullinan Oncology : Corporate Presentation December 2022
PU
2022Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2022Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
2022Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2022 Financial Re..
GL
2022Cullinan Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
2022Transcript : Cullinan Oncology, Inc. Presents at Credit Suisse 31st Annual He..
CI
2022Cullinan Oncology Announces the Appointment of David P. Ryan, M.D. to its Board of Dire..
GL
2022Cullinan Oncology Announces the Appointment of David P. Ryan, M.D. to its Board of Dire..
AQ
2022Cullinan Oncology Appoints of David P. Ryan to Its Board of Directors
CI
2022Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
More most relevant news
All news about CULLINAN ONCOLOGY, INC.
01/24Cullinan Oncology Says US FDA Approves Investigational New Drug Application for CLN-978
MT
01/24Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application ..
GL
01/24Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application ..
AQ
01/24Cullinan Oncology, Inc. Announces U.S. FDA Clearance of Investigational New Drug Applic..
CI
01/19Cullinan Oncology, Inc. : Unregistered Sale of Equity Securities, Amendments to Articles o..
AQ
01/06Cullinan Oncology : Corporate Presentation January 2023
PU
01/03Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2022Ikena Oncology Appoints Owen Hughes Board Chairman
MT
2022Cullinan Oncology : Corporate Presentation December 2022
PU
2022Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
More news
News in other languages on CULLINAN ONCOLOGY, INC.
01/24Cullinan Oncology déclare que la FDA américaine approuve la demande de nouveau médicame..
01/24Cullinan Oncology, Inc. annonce l'approbation par la FDA américaine de la demande d'aut..
2022Cullinan Oncology affiche une perte plus importante au troisième trimestre ; la trésore..
2022Cullinan Oncology, Inc. annonce ses résultats pour le troisième trimestre et les neuf m..
2022Cullinan Oncology nomme David P. Ryan à son conseil d'administration
2022Cullinan Oncology porte sa participation dans l'unité Cullinan MICA à 92 %.
2022Cullinan Oncology, Inc. nomme Jacquelyn Sumer au poste de directrice des affaires jurid..
2022Cullinan Oncology devient bénéficiaire au deuxième trimestre
2022Cullinan Oncology, Inc. annonce ses résultats pour le deuxième trimestre et les six moi..
2022Vente d'initiés : Cullinan Oncology
More news
Analyst Recommendations on CULLINAN ONCOLOGY, INC.
2021Cullinan Oncology : Morgan Stanley Adjusts Cullinan Oncology's Price T..
MT
2021Cullinan Oncology : HC Wainwright Adjusts Cullinan Management PT to $5..
MT
2021Cullinan Oncology : SVB Leerink Adjusts Price Target on Cullinan Manag..
MT
2021Cullinan Oncology : Morgan Stanley Upgrades Cullinan Management to Ove..
MT
2021Cullinan Oncology : Morgan Stanley Adjusts Price Target on Cullinan Ma..
MT
More recommendations
Press releases
01/24Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application ..
GL
01/24Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application ..
AQ
01/19Cullinan Oncology, Inc. : Unregistered Sale of Equity Securities, Amendments to Articles o..
AQ
01/06Cullinan Oncology : Corporate Presentation January 2023
PU
01/03Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
More press releases